"Year to date" sales for 2021, 2022, 2023, and 2024 sales are shown in series at the top of the table and then just below a comparison of 2024 versus 2023 and 2024 versus 2022 is displayed.

The company EBITDA went up by 15 per cent YoY to Rs 4,802 crore. The company has also upgraded FY25 EBITDA forecast to Rs 18,800-18,900 crore. During the 9 month period of FY25, APSEZ clocked ...

Profit rises by 19.34% to Rs 98.1 crore Dr Lal PathLabs Ltd on Thursday reported a profit of Rs 98.1 crore during the third quarter of FY25, posting a growth of 19.34 per cent in comparison to Rs ...

I needed to double that six-month quote for a true comparison. Car insurance costs vary substantially — from one company to the next and from one driver to the next. That’s because each ...

The Trump administration is slashing federal grants. The New York Times wants to talk to nonprofits that have lost funding — or fear they might. By David A. Fahrenthold David Fahrenthold is an ...

Sees FY25 adjusted revenue at least $252,000. Sees FY25 capital expenditures $1.4B. Sees FY25 effective tax rate 19%. The company said, “The Cigna (CI) Group’s outlook2 for full year 2025 ...

Paramount’s decision to nix funding comes during a financially perilous time for the storied media conglomerate. Last year, the company laid off 15% of its US staff and wrote down $6 billion in ...